Work

Long-Term Follow up and Optimized Dosing Regimen of INCB018424 in Patients with Myelofibrosis: Durable Clinical, Functional and Symptomatic Responses with Improved Hematological Safety.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.756.756

Authors: Srdan Verstovsek, Hagop Kantarjian, Ruben A. Mesa, Jorge Cortes-Franco, Animesh D. Pardanani, Deborah A. Thomas, Zeev Estrov, Edward C Bradley, Susan Erickson-Viitanen, Kris Vaddi, Richard Levy, Ayalew Tefferi

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic in Arizona, Mayo Clinic, Incyte (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980047232

FWCI: 2.567

Cites:

Cited by: 18

Related to: 10